Development of a homogeneous assay for measurement of small dense LDL cholesterol

Clinical Chemistry

Volumn 57, Issue 1, 2011, Pages 57-65

  Ito, Yasuki ^a   Fujimura, Miki ^a   Ohta, Motoko ^a   Hirano, Tsutomu ^b  

^a DENKA COMPANY LIMITED   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTERASE; CHOLESTEROL OXIDASE; ETHYLENE DERIVATIVE; HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHOLIPASE; MAGNESIUM; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SMALL DENSE LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; AUTOANALYZER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; NORMAL HUMAN; PRECIPITATION; ULTRACENTRIFUGATION;

CHOLESTEROL OXIDASE; CHOLESTEROL, LDL; ETHERS; HUMANS; POLYETHYLENE GLYCOLS; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SPHINGOMYELIN PHOSPHODIESTERASE; STEROL ESTERASE; SURFACE-ACTIVE AGENTS;

EID: 78650997400     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.149559     Document Type: Article

References (24)

1. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002;43:1363-79.
2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
3. Austin MA, King MC, Viranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
4. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense lowdensity lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997;95:69-75.
5. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoproteins particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
6. St-Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard P-M, Despres JP, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men. Arterioscler Thromb Vasc Biol 2005;25:553-9.
7. Swinkels DW, Hak-Lemmers HLM, Demacker PNM. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res 1987;28:1233-9.
8. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986;128:417-33.
9. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992;38:1632-8.
10. Okazaki M, Usui S, Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of lipoprotein testing. 2nd ed. Washington (DC): AACC Press; 2000. p 647-69.
11. Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple test method for quantification of small, dense LDL. J Lipid Res 2003;44:2193-201.
12. Hirano T, Ito Y, Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb 2005;12:67-72.
13. Okada M, Matsui H, Ito Y, Fujiwara A, Inano K. Low-density lipoprotein cholesterol can be chemically measured: A new superior method. J Lab Clin Med 1998;132:195-201.
14. Liu M, Krul ES, Subbaiah PV. Effect of apoprotein B conformation on the activation of lysolecithin acyltransferase and lecithin: Cholesterol acyltransferase. Studies with subfractions of low density lipoproteins. J Biol Chem 1992; 267:5139-47.
15. Oörni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles: Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem 1998;273: 29127-34.
16. Xu X-X, Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J Biol Chem 1991;266:24849-58.
17. Pentikäinen MO, Lehtonen EMP, Kovanen PT. Aggregation and fusion of modified low density lipoprotein. J Lipid Res 1996;37:2638-49.
18. Hojjati MR, Jiang XC. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 2006;47: 673-6.
19. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
20. Nakata S, Petrie BL, Calomeni EP, Estes MK. Electron microscopy procedure influences detection of rotaviruses. J Clin Microbiol 1987;25: 1902-6.
21. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, et al. Risk factors of atherosclerotic diseases: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb 2007;14:267-77.
22. Kontush A, Therond P, Zerrad A, Couturier M, Négre-Salvayre A, de Souza JA, et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: Relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 2007;27:1843-9.
23. McNamara JR, Small DM, Li Z, Schaefer EJ. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res 1996; 37:1924-35.
24. Hirano T, Nohtomi K, Sato Y, Kamata K, Ito Y. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia. Atherosclerosis 2009;205: 603-7.